| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) | 
|---|
| 03/23/2011 | EP1578353B1 4-hydroxypiperidine derivatives useful as antimycobacterial agents | 
| 03/23/2011 | EP1140836B1 Amide compounds | 
| 03/23/2011 | CN101990532A Method for making methylpentamethylene diamine and methylpiperidine | 
| 03/23/2011 | CN101987833A Novel nilvaldipine crystal types and preparation method thereof | 
| 03/23/2011 | CN101195602B 1-deoxidization nojiri toxin derivant, production method and uses thereof | 
| 03/22/2011 | US7910774 Alternative synthesis of renin inhibitors and intermediates thereof | 
| 03/22/2011 | US7910743 Compounds, compositions and methods | 
| 03/22/2011 | US7910741 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient | 
| 03/22/2011 | US7910652 Polyamide molding materials with an improved flowability, the production thereof and its use | 
| 03/22/2011 | US7910608 Biphenyl compounds useful as muscarinic receptor antagonists | 
| 03/22/2011 | US7910607 Nitroxide free radical synergized antineoplastic agents | 
| 03/22/2011 | US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders | 
| 03/22/2011 | US7910078 using an aminoalcohol derived from 4-amino-2-butanol, which have a higher CO2 absorption capacity; global warming; e.g. 4-(diethylamino)-2-butanol or 4-(piperidino)-2-butanol | 
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives | 
| 03/22/2011 | CA2433603C Kappa opioid receptor ligands | 
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors | 
| 03/22/2011 | CA2333965C Method of enhancing lysosomal .alpha.-galactosidase a | 
| 03/17/2011 | WO2011030591A1 Zinc cluster | 
| 03/17/2011 | WO2011029896A1 Methods of preparation of muscarinic acetylcholine receptor antagonists | 
| 03/17/2011 | WO2011029808A1 Hsl inhibitors useful in the treatment of diabetes | 
| 03/17/2011 | WO2009084030A3 Improved process for the preparation of (1-benzyl-4-(5,6,- dimethoxyind anone-2-yl)methylpiperidine) hydrochloride-form iii | 
| 03/17/2011 | US20110065923 Process for production of carebastine | 
| 03/17/2011 | US20110065915 Catalysts for metathesis reactions including enantioselective olefin metathesis, and related methods | 
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands | 
| 03/17/2011 | US20110065717 Sulfoximine derivatives as factor xa inhibitors | 
| 03/17/2011 | US20110065707 New hsl inhibitors useful in the treatment of diabetes | 
| 03/17/2011 | CA2772588A1 Zinc cluster | 
| 03/17/2011 | CA2771452A1 Hsl inhibitors useful in the treatment of diabetes | 
| 03/16/2011 | EP2295419A2 Substituted tetracycline compounds | 
| 03/16/2011 | EP2295404A2 Substituted tetracycline compounds | 
| 03/16/2011 | EP2295402A2 Antibacterial agents | 
| 03/16/2011 | EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them | 
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists | 
| 03/16/2011 | CN101985433A Preparation method for alvimopan | 
| 03/16/2011 | CN101585804B Synthetic method of a fexofenadine hydrochloride | 
| 03/16/2011 | CN101367759B Synthesis of high-purity amlodipine besylate | 
| 03/16/2011 | CN101260075B Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament | 
| 03/15/2011 | US7906675 Compounds for the treatment of metabolic disorders | 
| 03/15/2011 | US7906655 5,5'-(1,2-ethynediyl)bis(2-((2S)-1-((2R)-2-phenylpropanoyl)-2-pyrrolidinyl)-1H-benzimidazole); inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds | 
| 03/15/2011 | US7906556 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors | 
| 03/15/2011 | US7906532 Indazole derivatives | 
| 03/15/2011 | US7906496 Carboxylic acid derivatives | 
| 03/15/2011 | CA2397681C Partially saturated calcium channel blockers | 
| 03/10/2011 | WO2011028927A1 Selective sphingosine-1-phosphate receptor antagonists | 
| 03/10/2011 | WO2011028860A2 Compounds and compositions for treating cancer | 
| 03/10/2011 | WO2011028775A1 Methods of treating orthomyxoviral infections | 
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof | 
| 03/10/2011 | WO2011027321A1 Dihalide germanium(ii) precursors for germanium-containing film depositions | 
| 03/10/2011 | WO2011027081A2 Novel derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof | 
| 03/10/2011 | WO2011026959A1 Novel ethane diamine hepcidin antagonists | 
| 03/10/2011 | WO2011026241A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy | 
| 03/10/2011 | US20110060145 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal | 
| 03/10/2011 | US20110060144 Method for manufacturing magnesium amides | 
| 03/10/2011 | US20110059981 New Pyridine Analogues V | 
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament | 
| 03/10/2011 | US20110059937 Il-8 receptor antagonists | 
| 03/10/2011 | US20110059931 Biphenyl compounds useful as muscarinic receptor antagonists | 
| 03/10/2011 | US20110059922 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers | 
| 03/10/2011 | CA2772875A1 Methods of treating orthomyxoviral infections | 
| 03/10/2011 | CA2772807A1 Methods of treating poxviral infections | 
| 03/10/2011 | CA2772614A1 Compounds and compositions for treating cancer | 
| 03/10/2011 | CA2771592A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy | 
| 03/09/2011 | EP2292596A2 CETP activity inhibitor | 
| 03/09/2011 | EP2292590A2 Prodrugs of 9-aminomethyl tetracycline compounds | 
| 03/09/2011 | EP2292256A2 High mannose proteins and methods of making high mannose proteins | 
| 03/09/2011 | EP2032534B1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions | 
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | 
| 03/08/2011 | US7902368 Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines | 
| 03/08/2011 | US7902366 NK1 antagonists | 
| 03/08/2011 | US7902233 Compounds useful as pesticides | 
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors | 
| 03/08/2011 | US7902191 Histamine H3 receptor antagonists, preparation and therapeutic uses | 
| 03/08/2011 | US7902181 Compounds 010 | 
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists | 
| 03/03/2011 | WO2011025790A1 Macrocyclic hopo chelators | 
| 03/03/2011 | WO2011023954A2 Polymorphic forms of manidipine | 
| 03/03/2011 | WO2011023667A1 Carbocyclic glyt1 receptor antagonists | 
| 03/03/2011 | WO2010128528A9 Piperidine derivatives useful for treatment of diebetes | 
| 03/03/2011 | US20110054178 Process for the manufacture of [phenylsulfanylphenyl]piperidines | 
| 03/03/2011 | US20110053987 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same | 
| 03/03/2011 | US20110053985 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | 
| 03/03/2011 | US20110053984 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | 
| 03/03/2011 | US20110053975 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | 
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 | 
| 03/03/2011 | US20110053938 Compounds and Compositions For Treating Cancer | 
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists | 
| 03/03/2011 | US20110053901 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase | 
| 03/03/2011 | US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors | 
| 03/03/2011 | CA2772499A1 Polymorphic forms of manidipine | 
| 03/03/2011 | CA2772386A1 Tetracycline compounds | 
| 03/03/2011 | CA2767901A1 Carbocyclic glyt1 receptor antagonists | 
| 03/02/2011 | EP2289879A1 Synthesis of a crytalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt | 
| 03/02/2011 | EP2289878A1 Fexofenadine polymorphs and process for the preparation thereof | 
| 03/02/2011 | EP2288594A1 Imidazolidine derivatives | 
| 03/02/2011 | CN1939916B Compound for treating AIDS | 
| 03/01/2011 | US7897778 Benzamide compounds | 
| 03/01/2011 | US7897777 resolving a racemic mixture of racemic threo-methylphenidate hydrochloride with a less than stoichiometric amount of tertiary amine base to obtain a methylphenidate-chiral acid salt, basifying salt to obtain methylphenidate free base, and converting free base into d-threo-methylphenidate hydrochloride | 
| 03/01/2011 | US7897622 Viral polymerase inhibitors | 
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same | 
| 02/24/2011 | WO2010129057A8 Tetracycline compounds |